Patent · US Active

2-oxa-5-azabicyclo[2.2.1]heptan-3-yl derivatives

US9790230B2 · kind B2 · utility

2Cited by

0References

10Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Giuseppe Cecere · Basel, CH
Guido Galley · Rheinfelden (Baden), DE
Yimin Hu · Shanghai, CN
Roger Norcross · Olsberg, CH
Philippe Pflieger · Schwoben, FR
Hong Shen · Shanghai, CN

Key dates

Filing date	Jan 26, 2017
Grant date	Oct 17, 2017
Priority date	—
Expiry date	Jan 26, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula of formula I wherein X, L and R1 are as described herein, compositions containing compounds of formula I, methods of manufacture of compounds of formula I and methods of treating psychiatric, metabolic, cardiovascular or sleep disorders with compounds of formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.